Variant report
Variant | nsv970148 |
---|---|
Chromosome Location | chr6:85901688-85904720 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs58739470 | chr6:85901730-85901731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs3966883 | chr6:85901744-85901745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150299930 | chr6:85901778-85901779 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4053811 | chr6:85901798-85901799 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs1321752 | chr6:85901826-85901827 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs56988579 | chr6:85901833-85901834 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs536739039 | chr6:85901886-85901887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4053812 | chr6:85901897-85901898 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs569383487 | chr6:85901908-85901909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs137858361 | chr6:85901910-85901911 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537751873 | chr6:85901983-85901984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs578014787 | chr6:85901991-85901992 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558957466 | chr6:85902020-85902021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543915788 | chr6:85902036-85902037 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs58193637 | chr6:85902056-85902057 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs541263177 | chr6:85902085-85902086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559500320 | chr6:85902095-85902096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1590235 | chr6:85902126-85902127 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs1590236 | chr6:85902138-85902139 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs1590237 | chr6:85902191-85902192 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs73752205 | chr6:85902198-85902199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534072596 | chr6:85902203-85902204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9344467 | chr6:85902336-85902337 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs9344468 | chr6:85902366-85902367 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs9353253 | chr6:85902375-85902376 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs77156022 | chr6:85902391-85902392 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146916142 | chr6:85902415-85902416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530220262 | chr6:85902444-85902445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs548346659 | chr6:85902445-85902446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570054162 | chr6:85902470-85902471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537017305 | chr6:85902495-85902496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555907592 | chr6:85902536-85902537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570838244 | chr6:85902549-85902550 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9450182 | chr6:85902579-85902580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9444303 | chr6:85902585-85902586 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs115245901 | chr6:85902592-85902593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192269408 | chr6:85902677-85902678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs117015259 | chr6:85902684-85902685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554343019 | chr6:85902690-85902691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs117279347 | chr6:85902709-85902710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139330721 | chr6:85902710-85902711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564869004 | chr6:85902712-85902713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549448672 | chr6:85902719-85902720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs532488337 | chr6:85902722-85902723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569450882 | chr6:85902747-85902748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117756274 | chr6:85902796-85902797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529822034 | chr6:85902799-85902800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184560311 | chr6:85902840-85902841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190660787 | chr6:85902884-85902885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535227875 | chr6:85902896-85902897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:85897600-85902600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr6:85900600-85903000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr6:85901000-85903000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr6:85901200-85902400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr6:85901200-85903000 | Enhancers | Osteobl | bone |
6 | chr6:85901600-85902200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr6:85901600-85902200 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr6:85901600-85902800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr6:85901600-85902800 | Enhancers | NHDF-Ad | bronchial |
10 | chr6:85901600-85903200 | Enhancers | HMEC | breast |
11 | chr6:85901800-85902800 | Enhancers | HSMMtube | muscle |
12 | chr6:85902000-85902600 | Enhancers | HSMM | muscle |
13 | chr6:85902400-85902800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
14 | chr6:85902600-85903000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |